This week CDC discusses vaccine recommendations; a provider offers insights on administering live biotherapeutics; and early administration of simnotrelvir plus ritonavir shortened the time to sustained resolution of COVID-19 symptoms.
Canada’s Prison Needle Exchange Program: Reducing Hepatitis C at a Profit
World Hepatitis Day: Where Do We Go From Here?
Investigational Hepatitis D Therapy Well-Tolerated, Safe for Chronic Disease at Week 48
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Hepatitis C and Homelessness: Assessing Risk Factors
Global Hepatitis C Rates Persist Despite Curative Treatments